Ironwood Pharmaceuticals, Inc. (IRWD)

4.36 -0.07 (-1.58%) USD  |  NASDAQ  |  Apr 20, 11:07
More

Ironwood Pharmaceuticals SG&A Expense (Quarterly) : 19.29M for Dec. 31, 2025

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for IRWD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
AbbVie, Inc. 3.895B
Recursion Pharmaceuticals, Inc. 33.66M
Cytokinetics, Inc. 91.72M
Geron Corp. 41.67M
Ionis Pharmaceuticals, Inc. 130.00M